SEC Form D · Amendment · filed May 26, 2017
Kleo Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Declan Doogan · Palm Coast, FLDirectorJohn W. Childs · Waltham, MADirectorDouglas G. Manion · New Haven, CTExecCharles G. Drake · New York, NYDirectorRoy Prieb · New Haven, CTExec · DirectorDavid Spiegel · New Haven, CTExec · DirectorMatthew Boehm · Tysons, VAExec · DirectorCecelia D. Noreen · Lopez Island, WADirectorJoel Davidson · Luxembourg, LuxembourgExecTimothy Davenport · Tysons, VADirectorJoanne J. Fitzgerald · Luxembourg, LuxembourgExec · DirectorCorson Ellis · Tysons, VADirectorJennifer D. Schneider · Mountain View, CADirectorAndrew D. Page · Mountain View, CAExec · DirectorJoe D. Carey · Mountain View, CADirectorErica J. Palsis · Mountain View, CADirectorDave D. Engberg · Mountain View, CAExec · DirectorJody Flaws · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗